Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 5895184, 9 pages
http://dx.doi.org/10.1155/2016/5895184
Research Article

The Rhizome Mixture of Anemarrhena asphodeloides and Coptis chinensis Attenuates Mesalazine-Resistant Colitis in Mice

1Department of Life and Nanopharmaceutical Sciences and Department of Pharmacy, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea
2DongWha Pharm Research Institute, 35-71 Topsil-ro, Giheung-gu, Yongin-Shi, Gyeonggi 446-902, Republic of Korea

Received 22 June 2016; Revised 18 August 2016; Accepted 18 August 2016

Academic Editor: Man Hee Rhee

Copyright © 2016 Su-Min Lim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Du, T. Hudcovic, J. Mrazek et al., “Development of gut inflammation in mice colonized with mucosa-associated bacteria from patients with ulcerative colitis,” Gut Pathogens, vol. 7, article 32, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. K. J. Maloy and F. Powrie, “Intestinal homeostasis and its breakdown in inflammatory bowel disease,” Nature, vol. 474, no. 7351, pp. 298–306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. B. Hanauer, “Review article: the long-term management of ulcerative colitis,” Alimentary Pharmacology and Therapeutics, vol. 20, supplement 4, pp. 97–101, 2004. View at Google Scholar · View at Scopus
  4. A. Andoh, Y. Yagi, M. Shioya, A. Nishida, T. Tsujikawa, and Y. Fujiyama, “Mucosal cytokine network in inflammatory bowel disease,” World Journal of Gastroenterology, vol. 14, no. 33, pp. 5154–5161, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Monteleone, M. Sarra, F. Pallone, and G. Monteleone, “Th17-related cytokines in inflammatory bowel diseases: friends or foes?” Current Molecular Medicine, vol. 12, no. 5, pp. 592–597, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. I. C. Roberts-Thomson, J. Fon, W. Uylaki, A. G. Cummins, and S. Barry, “Cells, cytokines and inflammatory bowel disease: a clinical perspective,” Expert Review of Gastroenterology and Hepatology, vol. 5, no. 6, pp. 703–716, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. L. Wallace, L.-B. Zheng, Y. Kanazawa, and D. Q. Shih, “Immunopathology of inflammatory bowel disease,” World Journal of Gastroenterology, vol. 20, no. 1, pp. 6–21, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. H. Chang and C. Dong, “IL-17F: regulation, signaling and function in inflammation,” Cytokine, vol. 46, no. 1, pp. 7–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Qu, M. Xu, I. Mizoguchi et al., “Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases,” Clinical and Developmental Immunology, vol. 2013, Article ID 968549, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Yang, M. S. Sundrud, J. Skepner, and T. Yamagata, “Targeting Th17 cells in autoimmune diseases,” Trends in Pharmacological Sciences, vol. 35, no. 10, pp. 493–500, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Noack and P. Miossec, “Th17 and regulatory T cell balance in autoimmune and inflammatory diseases,” Autoimmunity Reviews, vol. 13, no. 6, pp. 668–677, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Shen, M. J. Ruddy, P. Plamondon, and S. L. Gaffen, “Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-α-induced genes in bone cells,” Journal of Leukocyte Biology, vol. 77, no. 3, pp. 388–399, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Gyires, É. V. Tóth, and S. Z. Zádori, “Gut inflammation: current update on pathophysiology, molecular mechanism and pharmacological treatment modalities,” Current Pharmaceutical Design, vol. 20, no. 7, pp. 1063–1081, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. G. Reddy and E. V. Loftus Jr., “Safety of infliximab and other biologic agents in the inflammatory bowel diseases,” Gastroenterology Clinics of North America, vol. 35, no. 4, pp. 837–855, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J.-J. Jeong, S.-E. Jang, S. R. Hyam, M. J. Han, and D.-H. Kim, “The rhizome mixture of Anemarrhena asphodeloides and coptidis chinensis ameliorates acute and chronic colitis in mice by inhibiting the binding of lipopolysaccharide to TLR4 and IRAK1 phosphorylation,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 809083, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Lim, J. Jeong, H. S. Choi, H. B. Chang, and D. Kim, “Mangiferin corrects the imbalance of Th17/Treg cells in mice with TNBS-induced colitis,” International Immunopharmacology, vol. 34, pp. 220–228, 2016. View at Publisher · View at Google Scholar
  17. K.-A. Kim, W. Gu, I.-A. Lee, E.-H. Joh, and D.-H. Kim, “High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway,” PLoS ONE, vol. 7, no. 10, Article ID e47713, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S.-M. Lim, G.-D. Kang, J.-J. Jeong, H. S. Choi, and D.-H. Kim, “Neomangiferin modulates the Th17/Treg balance and ameliorates colitis in mice,” Phytomedicine, vol. 23, no. 2, pp. 131–140, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. Isidro and C. B. Appleyard, “Colonic macrophage polarization in homeostasis, inflammation, and cancer,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 311, no. 1, pp. G59–G73, 2016. View at Publisher · View at Google Scholar
  20. C. A. Ambarus, S. Krausz, M. van Eijk et al., “Systematic validation of specific phenotypic markers for in vitro polarized human macrophages,” Journal of Immunological Methods, vol. 375, no. 1-2, pp. 196–206, 2012. View at Publisher · View at Google Scholar · View at Scopus